JP2010111679A5 - - Google Patents

Download PDF

Info

Publication number
JP2010111679A5
JP2010111679A5 JP2009288124A JP2009288124A JP2010111679A5 JP 2010111679 A5 JP2010111679 A5 JP 2010111679A5 JP 2009288124 A JP2009288124 A JP 2009288124A JP 2009288124 A JP2009288124 A JP 2009288124A JP 2010111679 A5 JP2010111679 A5 JP 2010111679A5
Authority
JP
Japan
Prior art keywords
antigen
monoclonal antibody
composition
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009288124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010111679A (ja
JP5199228B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010111679A publication Critical patent/JP2010111679A/ja
Publication of JP2010111679A5 publication Critical patent/JP2010111679A5/ja
Application granted granted Critical
Publication of JP5199228B2 publication Critical patent/JP5199228B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009288124A 2002-02-21 2009-12-18 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体 Expired - Fee Related JP5199228B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US35882402P 2002-02-21 2002-02-21
US60/358,824 2002-02-21
US38306802P 2002-05-23 2002-05-23
US60/383,068 2002-05-23
US43149902P 2002-12-05 2002-12-05
US60/431,499 2002-12-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004508271A Division JP4488351B2 (ja) 2002-02-21 2003-02-21 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012248466A Division JP5271443B2 (ja) 2002-02-21 2012-11-12 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体

Publications (3)

Publication Number Publication Date
JP2010111679A JP2010111679A (ja) 2010-05-20
JP2010111679A5 true JP2010111679A5 (https=) 2011-05-06
JP5199228B2 JP5199228B2 (ja) 2013-05-15

Family

ID=33425052

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2004508271A Expired - Fee Related JP4488351B2 (ja) 2002-02-21 2003-02-21 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体
JP2008325146A Expired - Fee Related JP4514820B2 (ja) 2002-02-21 2008-12-22 可溶型の炭酸脱水酵素IX(s−CA IX)、s−CA IXを検出するためのアッセイ、CA IXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCA IX特異的モノクローナル抗体
JP2009288124A Expired - Fee Related JP5199228B2 (ja) 2002-02-21 2009-12-18 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体
JP2012248466A Expired - Fee Related JP5271443B2 (ja) 2002-02-21 2012-11-12 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2004508271A Expired - Fee Related JP4488351B2 (ja) 2002-02-21 2003-02-21 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体
JP2008325146A Expired - Fee Related JP4514820B2 (ja) 2002-02-21 2008-12-22 可溶型の炭酸脱水酵素IX(s−CA IX)、s−CA IXを検出するためのアッセイ、CA IXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCA IX特異的モノクローナル抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012248466A Expired - Fee Related JP5271443B2 (ja) 2002-02-21 2012-11-12 可溶型の炭酸脱水酵素IX(s−CAIX)、s−CAIXを検出するためのアッセイ、CAIXとHER−2/neu/c−erbB−2の同時発現、非免疫優性エピトープに対するCAIX特異的モノクローナル抗体

Country Status (8)

Country Link
US (5) US7846673B2 (https=)
EP (1) EP1487972B1 (https=)
JP (4) JP4488351B2 (https=)
AU (1) AU2003217606C1 (https=)
CA (1) CA2477163C (https=)
DK (2) DK3031910T3 (https=)
HU (3) HUE026218T2 (https=)
WO (1) WO2004005348A1 (https=)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508596B1 (en) * 2002-02-21 2015-08-12 Institute Of Virology MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use
DK3031910T3 (en) * 2002-02-21 2017-10-23 Inst Virology MN / CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED BY MN / CA IX-DEFICIENT MOUSE AND METHODS OF USE
US20090162382A1 (en) * 2002-03-01 2009-06-25 Bernett Matthew J Optimized ca9 antibodies and methods of using the same
EP1501939B1 (en) * 2002-04-16 2009-07-22 The Regents of The University of California Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix
US20090239247A1 (en) * 2002-12-13 2009-09-24 Harris Adrian L MN and Hypoxia
CN102746336B (zh) 2005-06-29 2015-08-19 施瑞修德制药公司 氨基磷酸酯烷化剂前体药物
EP2837697B1 (en) * 2006-10-10 2016-12-07 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Prostate cancer-specific alterations in ERG gene expression and detection methods based on those alternations
US7820159B2 (en) * 2006-10-31 2010-10-26 Instiute of Virology of the Slovak Academy of Sciences MN/CA IX and EGFR pathway inhibition
EP2219668A1 (en) * 2007-11-02 2010-08-25 Wilex AG Binding epitopes for g250 antibody
CN101868445B (zh) 2007-11-19 2014-06-18 旭化成化学株式会社 异氰酸酯和芳香族羟基化合物的制造方法
ES2890501T3 (es) 2009-03-02 2022-01-20 Massachusetts Inst Technology Métodos y productos para la creación de perfiles enzimáticos in vivo
EP2295975B1 (en) * 2009-09-10 2014-06-18 Bruker Daltonik GmbH Determining the expression status of human epidermal growth factor receptor 2 (HER2) in biological samples
CA2830235C (en) 2011-03-15 2023-10-24 Massachusetts Institute Of Technology Multiplexed detection with isotope-coded reporters
US9080849B2 (en) 2011-07-29 2015-07-14 Milwaukee Electric Tool Corporation Tape measure
CA2784047C (en) 2011-07-29 2015-08-11 Milwaukee Electric Tool Corporation Tape measure
US8863399B2 (en) 2011-08-26 2014-10-21 Milwaukee Electric Tool Corporation Tape measure
EP2508890A1 (en) * 2011-10-25 2012-10-10 Roche Diagnostics GmbH CAIX based diagnosis of heart failure
WO2013096687A1 (en) 2011-12-22 2013-06-27 Threshold Pharmaceuticals, Inc. Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer
US9267778B2 (en) 2012-01-19 2016-02-23 Milwaukee Electric Tool Corporation Tape measure
EP2810076A4 (en) * 2012-01-31 2015-07-01 Threshold Pharmaceuticals Inc PRÄDIKTIVER BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUGTHERAPY
JP2015155795A (ja) * 2012-05-21 2015-08-27 東レ株式会社 癌の検出方法
USD733597S1 (en) 2012-07-30 2015-07-07 Milwaukee Electric Tool Corporation Tape measure
CN104837502B (zh) 2012-10-12 2018-08-10 麦迪穆有限责任公司 吡咯并苯并二氮杂卓及其结合物
CA2905181C (en) 2013-03-13 2020-06-02 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
JP6847660B2 (ja) * 2013-06-07 2021-03-24 マサチューセッツ インスティテュート オブ テクノロジー リガンドをコードする合成バイオマーカーのアフィニティベースの検出
US10071109B2 (en) 2013-11-06 2018-09-11 Molecular Templates, Inc. Predictive biomarker for hypoxia-activated prodrug therapy
JP6531166B2 (ja) 2014-09-10 2019-06-12 メドイミューン・リミテッドMedImmune Limited ピロロベンゾジアゼピン及びそのコンジュゲート
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
EP3286337A4 (en) * 2015-04-23 2018-12-12 Cedars-Sinai Medical Center Automated delineation of nuclei for three dimensional (3-d) high content screening
USD785476S1 (en) 2015-12-10 2017-05-02 Milwaukee Electric Tool Corporation Tape measure
USD785475S1 (en) 2015-12-10 2017-05-02 Milwaukee Electric Tool Corporation Tape measure
USD783429S1 (en) 2016-01-07 2017-04-11 Milwaukee Electric Tool Corporation Tape measure
USD783430S1 (en) 2016-01-07 2017-04-11 Milwaukee Electric Tool Corporation Tape measure
USD787347S1 (en) 2016-01-07 2017-05-23 Milwaukee Electric Tool Corporation Tape measure
WO2017177115A1 (en) 2016-04-08 2017-10-12 Massachusetts Institute Of Technology Methods to specifically profile protease activity at lymph nodes
US11428689B2 (en) 2016-05-05 2022-08-30 Massachusetts Institute Of Technology Methods and uses for remotely triggered protease activity measurements
USD788611S1 (en) 2016-06-01 2017-06-06 Milwaukee Electric Tool Corporation Tape measure
CN109862919A (zh) 2016-10-11 2019-06-07 免疫医疗有限公司 抗体-药物缀合物联合免疫介导的治疗剂
WO2018115203A1 (en) 2016-12-23 2018-06-28 Bicyclerd Limited Peptide derivatives having novel linkage structures
CA3059358A1 (en) 2017-04-07 2018-10-11 Massachusetts Institute Of Technology Methods to spatially profile protease activity in tissue and sections
WO2018197893A1 (en) 2017-04-27 2018-11-01 Bicycletx Limited Bicyclic peptide ligands and uses thereof
JP7301757B2 (ja) 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用
CN111183147B (zh) 2017-08-04 2024-07-05 拜斯科技术开发有限公司 Cd137特异性的双环肽配体
GB201721265D0 (en) 2017-12-19 2018-01-31 Bicyclerd Ltd Bicyclic peptide ligands specific for EphA2
TWI825046B (zh) 2017-12-19 2023-12-11 英商拜西可泰克斯有限公司 Epha2特用之雙環胜肽配位基
JP2021514953A (ja) 2018-02-23 2021-06-17 バイスクルテクス・リミテッド 多量体二環式ペプチドリガンド
US11054428B2 (en) 2018-03-05 2021-07-06 Massachusetts Institute Of Technology Inhalable nanosensors with volatile reporters and uses thereof
CA3098103A1 (en) 2018-05-23 2019-11-28 Adc Therapeutics Sa Molecular adjuvant
US11732009B2 (en) 2018-06-08 2023-08-22 Glympse Bio, Inc. Activity sensor with tunable analyte
US11028425B2 (en) 2018-06-08 2021-06-08 Glympse Bio, Inc. Diagnosis and monitoring of liver disease
GB201810316D0 (en) 2018-06-22 2018-08-08 Bicyclerd Ltd Peptide ligands for binding to EphA2
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
EP3856921B1 (en) 2018-09-25 2026-04-29 Massachusetts Institute Of Technology Lung protease nanosensors and uses thereof
WO2020084305A1 (en) 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
JP2022514618A (ja) 2018-12-21 2022-02-14 バイスクルテクス・リミテッド Pd-l1に特異的な二環式ペプチドリガンド
US12551567B2 (en) 2018-12-21 2026-02-17 Bicyclerd Limited Bicyclic peptide ligands specific for PD-L1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
WO2020150560A1 (en) 2019-01-17 2020-07-23 Massachusetts Institute Of Technology Sensors for detecting and imaging of cancer metastasis
JP7740987B2 (ja) 2019-02-28 2025-09-17 ジョージア・テック・リサーチ・コーポレーション 生物学的活性の論理ゲート化プロファイリングのための組成物および方法
WO2020226612A1 (en) * 2019-05-06 2020-11-12 Navi Bio-Therapeutics, Llc Anti-carbonic anhydrase ix antibody
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
MX2022005332A (es) * 2019-11-05 2022-05-26 Mabpro A S Anticuerpos anti-ca ix humanizados y metodos de su uso.
CN111273036B (zh) * 2020-03-06 2021-06-15 中国农业科学院兰州兽医研究所 检测口蹄疫非结构蛋白抗体的单抗竞争化学发光试剂盒
IL300248A (en) 2020-08-03 2023-03-01 Bicycletx Ltd peptide-based linkers
EP4211468A4 (en) 2020-09-11 2024-10-09 Glympse Bio, Inc. DETECTION OF EX VIVO PROTEASE ACTIVITY FOR DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT OF DISEASES
US20230372528A1 (en) 2020-10-16 2023-11-23 University Of Georgia Research Foundation, Inc. Glycoconjugates
GB202102396D0 (en) 2021-02-19 2021-04-07 Adc Therapeutics Sa Molecular adjuvant
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联
CN116167592B (zh) * 2023-04-20 2023-06-23 交通运输部天津水运工程科学研究所 一种河流溢油风险防控和决策支持系统

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401638A (en) 1986-06-04 1995-03-28 Oncogene Science, Inc. Detection and quantification of neu related proteins in the biological fluids of humans
US4968603A (en) 1986-12-31 1990-11-06 The Regents Of The University Of California Determination of status in neoplastic disease
US6204370B1 (en) 1992-03-11 2001-03-20 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US5989838A (en) 1992-03-11 1999-11-23 Institute Of Virology, Slovak Academy Of Sciences Immunological methods of detecting MN proteins and MN polypeptides
US6774117B1 (en) 1992-03-11 2004-08-10 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6027887A (en) 1992-03-11 2000-02-22 Institute Of Virology, Solvak Academy Of Sciences MN gene and protein
US6093548A (en) 1992-03-11 2000-07-25 Institute Of Virology, Slovak Academy Of Sciences Detection and quantitation of MN-specific antibodies.
US5981711A (en) 1992-03-11 1999-11-09 Institute Of Virology, Slovak Academy Of Sciences MN-specific antibodies and hybridomas
US6297051B1 (en) 1997-01-24 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6069242A (en) 1992-03-11 2000-05-30 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6297041B1 (en) * 1992-03-11 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US5972353A (en) 1992-03-11 1999-10-26 Institute Of Virology, Slovak Academy Of Sciences MN proteins, polypeptides, fusion proteins and fusion polypeptides
US5955075A (en) 1992-03-11 1999-09-21 Institute Of Virology, Slovak Academy Of Sciences Method of inhibiting tumor growth using antibodies to MN protein
US5387676A (en) * 1992-03-11 1995-02-07 Ciba Corning Diagnostics Corp. MN gene and protein
CA2192678C (en) * 1994-06-15 2010-12-14 Jan Zavada Mn gene and protein
US6451977B1 (en) * 1998-02-26 2002-09-17 Genentech, Inc. Fused polypeptides
JP3910798B2 (ja) 1998-10-23 2007-04-25 インスティトゥート オブ ヴァイロロジー Mn遺伝子およびタンパク質
AU2002351208A1 (en) * 2001-12-03 2003-06-17 Abgenix, Inc. Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
DK3031910T3 (en) * 2002-02-21 2017-10-23 Inst Virology MN / CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED BY MN / CA IX-DEFICIENT MOUSE AND METHODS OF USE
EP1576010A4 (en) 2002-08-23 2006-12-27 Chiron Corp THERAPEUTIC COMPOSITIONS AND METHODS FOR CANCER CHARACTERIZED BY EXPRESSION OF MN / CA IX ANTIGEN ASSOCIATED WITH TUMORS
WO2008103327A2 (en) 2007-02-20 2008-08-28 Bayer Pharmaceuticals Corporation Mn/ca ix and bladder cancer
EP2219668A1 (en) * 2007-11-02 2010-08-25 Wilex AG Binding epitopes for g250 antibody

Similar Documents

Publication Publication Date Title
JP2010111679A5 (https=)
AU2011255870B2 (en) Anti-human TROP-2 antibody having antitumor activity in vivo
CN103068851B (zh) 内质蛋白的抗体及其用途
JP2010535713A5 (https=)
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
JP2012523848A5 (https=)
JP2020515235A5 (https=)
JP2016500655A5 (https=)
JP5836125B2 (ja) 高分子量メラノーマ関連抗原に対する完全ヒト抗体およびその使用
US8105598B2 (en) Human monoclonal antibodies that specifically bind IGF-II
US9676846B2 (en) Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
BRPI0619606A2 (pt) anticorpos anti-mn e métodos de uso dos mesmos
CN109219446B (zh) Alk7结合蛋白及其用途
JP7713995B2 (ja) ヒトpd-l1およびpd-l2に対する二重特異性抗体およびその使用方法
JP2014515600A5 (https=)
CN103025760A (zh) 人源化egfr抗体
CN105452297A (zh) mAb 2抗-Met抗体
CN104530236A (zh) 一种全人源her2抗体、其编码基因及应用
CN109476757B (zh) 抗-axl受体酪氨酸激酶抗体及其用途
CN111194222A (zh) 与xCT抗体相关的组合物和方法
US7824681B2 (en) Human monoclonal antibodies that specifically bind IGF-II
CN118515777A (zh) 双价或多价抗体的构建体、其建立方法及应用
TW201125580A (en) Anti- α -enolase I antibodies for diagnosis and treatment of α -enolase I-associated diseases
CN120535630B (zh) 一种靶向cdh17的大羊驼纳米抗体、结合分子及其应用
CN120535623B (zh) Cdh17结合分子及其用途